Dec 3 (Reuters) - Nuvo Research Inc NRI.TO :
* Research provides update on pennsaid 2% phase 3 clinical trial
* Says expects the trial to be completed and top line results available in Q1
2016
* Says top line results expected in Q1 2016
* Trial is being conducted to support regulatory applications for marketing
approval of pennsaid 2% in e.u., Canada and Australia
Source text for Eikon
Further company coverage NRI.TO